Storz Medical AG
11
2
2
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
18.2%
2 terminated/withdrawn out of 11 trials
66.7%
-19.8% vs industry average
18%
2 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Extracorporeal Shockwave Therapy and Platelet-Rich Plasma for Midportion Achilles Tendinopathy
Role: collaborator
PMCF Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones
Role: lead
German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation
Role: collaborator
Brain Stimulation for Neurological Patients
Role: lead
Long Term Transcranial Pulse Stimulation (TPS) on Older Adults With Mild Neurocognitive Disorder (NCD)
Role: collaborator
Cardiac Shock Wave Treatment in Patients With Reduced Coronary Flow Reserve
Role: lead
Brain Stimulation for Patients With Parkinson Disease
Role: lead
Transcranial Pulse Stimulation Open-label Self-controlled Trial For Mild Neurocognitive Disorder
Role: collaborator
Transcranial Pulse Stimulation (TPS) for Alzheimer's Disease (AD)
Role: lead
Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome
Role: lead
Pilot Study of the Treatment of Erectile Dysfunction (ED) With Extracorporeal Shockwave Therapy (ESWT)
Role: lead
All 11 trials loaded